Skip to content
IKT Inhibikase Therapeutics, Inc. Common Stock
$2.40 1.27% +0.03
Notify me if price changes either direction
Interactive Brokers Logotype

Buy IKT stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 172.3M
Enterprise value 156.2M
Trailing PE -0.67226890756303
Forward PE -9.48
PEG Ratio -9.48
Enterprise to EBITDA -7.796
Enterprise to revenue 156.2M
Price to book MRQ -40.178156056171
Price to sales TTM 172.3M

Financials

Fiscal Year Ends 2023-12-31
Most Recent Quarter (MRQ) 2024-09-30
Revenue (TTM) 1
EBITDA -20037660
Diluted EPS TTM -3.12
Total Cash (MRQ) 3.2M
Current ratio (MRQ) 0.854
Operating Cash Flow (TTM) -17244924

IKT trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
75% sells
25% buys
Upgrade Today
In the last 0 months

Recent IKT News

Services

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.